Welcome to our dedicated page for MANNATECH SEC filings (Ticker: MTEX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Mannatech filings document the regulatory record for an operating health and wellness company that sells nutritional supplements, skin care and anti-aging products, and weight-management products through an independent associate and member network. Periodic and current reports disclose operating results, net sales, gross profit, commissions, foreign currency effects, regional demand, supply chain costs and customer and associate activity.
The company's SEC record also includes proxy materials covering director elections, auditor ratification and executive compensation votes; 8-K reports on financial results and leadership changes; Form 12b-25 late-filing notices; and disclosures related to Nasdaq continued-listing standards and stockholders' equity. These filings describe governance, capital-structure matters, reporting status and risk areas relevant to MTEX common stock.
Mannatech, Inc. (MTEX) announced a planned board leadership transition. J. Stanley Fredrick notified the Board of his intent to retire as director and Chairman of the Board for personal reasons, effective September 1, 2026, with no disagreement reported with the company.
The Board appointed Robert Toth, currently Vice Chairman and a Class III director, to become Chairman effective the same date. As a non‑employee director, he will receive standard director compensation plus, in his first year as chairman, an additional $50,000 and an equity component valued at $50,000, with the equity grant deferred until additional shares are approved under an incentive plan. In his second and third years as chairman, he will receive standard director compensation plus an additional $100,000 fee each year. As part of the transition, the Board agreed to continue Mr. Fredrick’s director retainer through December 31, 2026.
MANNATECH INC (MTEX) received an amended Schedule 13G/A (Amendment No. 2) reporting the equity holdings of Terry LaCore. LaCore reports beneficial ownership of 159,585 shares of Mannatech common stock, representing 8.27% of the class, with sole voting and dispositive power over all of these shares and no shared power.
The reported ownership percentage is calculated using 1,929,670 shares outstanding as of August 5, 2026, as disclosed by Mannatech in its Form 10-Q filed August 12, 2026. This amendment is described as correcting prior cover-page omissions in Amendment No. 1 rather than changing the underlying ownership position.
MANNATECH INC (MTEX) reports that investor Terry LaCore has filed Amendment No. 1 to a Schedule 13G regarding ownership of its common stock. LaCore reports beneficial ownership of 159,585 shares of Mannatech common stock, representing 8.27% of the class as of June 30, 2026.
LaCore reports sole power to votesole power to dispose of
Mannatech, Incorporated reported improved results for the quarter and six months ended June 30, 2026. Second-quarter 2026 net sales were $26.7 million, up from $25.7 million a year earlier, with constant-currency net sales rising 5.1%. Gross profit increased to $20.5 million, and constant-currency gross profit grew 10.1%.
The company generated income from operations of $1.0 million in the quarter, compared with a loss from operations of $1.4 million in 2025. Net income was $1.0 million, versus a net loss of $4.3 million a year earlier. For the first six months of 2026, net income was $2.0 million, compared with a net loss of $5.8 million in the prior-year period, while net sales were $51.6 million versus $52.2 million.
As of June 30, 2026, total assets were $27.5 million and total liabilities were $32.4 million, resulting in a shareholders’ deficit of $5.0 million. The company also presented non-GAAP constant dollar measures to highlight the impact of foreign currency on net sales, gross profit, and income from operations.
Mannatech, Incorporated reported improved results for the three and six months ended June 30, 2026 but continues to face liquidity pressure and a shareholders’ deficit. Net sales were $26.7 million for the quarter (up 3.8%) and $51.6 million for the first half (down 1.3%), with Asia/Pacific contributing about 60% of sales. Gross margin expanded to 76.9% in the quarter as cost of sales declined.
The company generated net income of $1.0 million in Q2 and $2.0 million year-to-date, compared with losses in 2025, aided by $1.7 million in net foreign currency gains over six months. Cash and cash equivalents were $6.0 million and working capital was $2.5 million, while total liabilities of $32.4 million exceeded total assets of $27.5 million, leaving a shareholders’ deficit of $5.0 million. Management disclosed that prior sales declines, operating losses and cost structure misalignment raise substantial doubt about the ability to continue as a going concern and outlined cost cuts, capital discipline, pricing and margin initiatives, and revenue stabilization efforts.
MANNATECH INC Chief Financial Officer Yasir Haider received a grant of 4,000 stock options on June 3, 2026. These options give him the right to purchase 4,000 shares of common stock at an exercise price of $5.77 per share until June 3, 2036.
According to the vesting terms, one-third of the options vest on the grant date, another one-third vests on the first anniversary, and the final one-third vests on the second anniversary of the grant. After this award, he holds 4,000 derivative securities directly.
Mannatech Inc filed an initial ownership report on Form 3 for Haider Yasir, who serves as Chief Financial Officer. The filing does not show any reportable holdings or transactions yet; it simply establishes his status as an officer subject to insider reporting rules going forward.
Mannatech, Incorporated announced that its Board of Directors appointed Yasir Haider as Chief Financial Officer and principal financial officer, effective June 3, 2026. He succeeds James Clavijo, who had served as CFO since July 2024 and is relinquishing the role to Haider.
Haider joined Mannatech on January 6, 2025 as Controller and was previously named Interim CFO on March 20, 2026 to support the transition. He brings prior experience as CFO and Financial Controller with responsibility for global financial operations, SEC reporting, M&A and building scalable finance infrastructure.
CEO Landen Fredrick highlighted Haider’s discipline in financial processes and focus on accountability, expressing confidence in his leadership as Mannatech works to improve performance and create long-term shareholder value. The company reiterates standard forward-looking statement cautions and operates in 25 markets through its global health and wellness business.
Mannatech Inc director Robert Toth received a new stock option grant. He was awarded the right to purchase 5,000 shares of Mannatech common stock at an exercise price of $5.77 per share, expiring on June 3, 2036.
According to the vesting terms, one-third of the options vest on the grant date, another one-third on the first anniversary, and the final one-third on the second anniversary. After this grant, Toth holds rights to purchase a total of 8,334 shares of Mannatech common stock directly.
Mannatech Inc director John A. Seifrick received a grant of stock options representing the right to purchase 5,000 shares of common stock at an exercise price of $5.77 per share. One-third of these options vest on the grant date, another one-third on the first anniversary, and the final third on the second anniversary of the grant date.
After this award, Seifrick directly holds rights to acquire a total of 11,807 shares. The award reflects equity-based compensation rather than an open-market stock purchase or sale.